Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial
磷脂纳米颗粒（VBI-S）逆转脓毒性休克患者难治性低血压的疗效和安全性：一项多中心、开放标签、重复测量的 IIa 期临床试验
期刊:EClinicalMedicine
影响因子:9.6
doi:10.1016/j.eclinm.2024.102430.
Cuthbert Simpkins,Michael Moncure,Heather Klepacz,Kristopher Roach,Sadia Benzaquen,Luis Diaz-Caballero,Jonathan Cohen,Daniel Haase,Mukesh Kumar,Harven DeShield,Anthony Manasia,Juan Rodriguez,Prashanth Anamthathmakula,Nik Hurt,Bhaswati Mukherjee,Krishna Talluri
